INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 410m ago
House PTR10m ago
SEC 13F9m ago
Robinhood Chain9m ago

Most active filers · 30d

  1. 01Kurtz George0B / 239S · 10 late239 trades$59.22M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08RJRubinstein Julie0B / 37S37 trades$6.25M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K

Form 4 transactions

21,973 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
15
KL
Kutua LubiCFO, Treasurer
BYNDBEYOND MEAT, INC.
Open-market sale · 10b5-1 plan
SELL$253K
419.0K sh
Apr 13, 2026Apr 15, 2026
Page 338 of 550
← PrevNext →
traded Apr 13, 2026
+2d
SEC Form 4

Evidence

15
FM
Fordyce MarshallDirector, PRESIDENT AND CEO
VERAVera Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$617K
14.1K sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC Form 4

Evidence

14
Siebel Thomas MDirector, Executive Chairman, 10% Owner
AIC3.ai, Inc.
Open-market sale · 10b5-1 plan
SELL$1.40M
165.3K sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC Form 4

Evidence

13
YS
Yi StevenDirector, See Remarks
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$36K
4,000 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

13
RM
Rodman David MalcomChief Medical Officer
MLYSMineralys Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$373K
14.1K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

13
Yuan Eric S.Director, Chief Executive Officer
ZMZoom Communications, Inc.
Open-market sale · 10b5-1 plan
SELL$46K
550 sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC Form 4

Evidence

13
IJ
Inrig JulaCHIEF MEDICAL OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$43K
1,018 sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC Form 4

Evidence

13
Yuan Eric S.Director, Chief Executive Officer
ZMZoom Communications, Inc.
Open-market sale · 10b5-1 plan
SELL$13K
155 sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC Form 4

Evidence

13
YS
Yi StevenDirector, See Remarks
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$39K
4,000 sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC Form 4

Evidence

13
YS
Yi StevenDirector, See Remarks
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$38K
4,000 sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC Form 4

Evidence

12
BG
Bexiga Annabelle GDirector
SNEXStoneX Group Inc.
Open-market sale · 10b5-1 plan
SELL$153K
1,500 sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC Form 4

Evidence

12
MC
Maroney Dawn ChristinePresident
ALHCAlignment Healthcare, Inc.
Open-market sale · 10b5-1 plan
SELL$626K
30.0K sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC Form 4

Evidence

11
FM
Fordyce MarshallDirector, PRESIDENT AND CEO
VERAVera Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$353K
7,921 sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC Form 4

Evidence

10
RM
Rodman David MalcomChief Medical Officer
MLYSMineralys Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$176K
6,348 sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC Form 4

Evidence

9
CJ
Congleton JonDirector, Chief Executive Officer
MLYSMineralys Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$422K
15.7K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

9
PJ
Pernice Thomas JDirector
TPETTrio Petroleum Corp
Open-market sale · 10b5-1 plan
SELL—
25.0K sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC Form 4

Evidence

9
IC
Indelicarto Thomas CEVP, Gen Counsel & Secretary
VRSNVERISIGN INC/CA
Open-market sale · 10b5-1 plan
SELL$134K
498 sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC Form 4

Evidence

9
RH
Robinson Mark HaymondGeneral Counsel and Secretary
GMEGameStop Corp.
Open-market sale · 10b5-1 plan
SELL$91K
3,912 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

8
SD
Spector DavidDirector, Chairman & CEO
PFSIPennyMac Financial Services, Inc.
Open-market sale · 10b5-1 plan
SELL$889K
9,583 sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC Form 4

Evidence

8
ML
Mater Tonya L.SVP & Chief Accounting Officer
EPREPR PROPERTIES
Open-market sale · 10b5-1 plan
SELL$112K
2,000 sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC Form 4

Evidence

7
BL
Brooks Jayme L.Chief Financial Officer
LMBLimbach Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$487K
5,703 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

7
SM
Slessor MikeDirector, CEO
FORMFORMFACTOR INC
Open-market sale · 10b5-1 plan
SELL$698K
5,432 sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC Form 4

Evidence

7
SM
Slessor MikeDirector, CEO
FORMFORMFACTOR INC
Open-market sale · 10b5-1 plan
SELL$302K
2,369 sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC Form 4

Evidence

5
FM
Fordyce MarshallDirector, PRESIDENT AND CEO
VERAVera Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$41K
900 sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC Form 4

Evidence

4
ML
Mater Tonya L.SVP & Chief Accounting Officer
EPREPR PROPERTIES
Open-market sale · 10b5-1 plan
SELL$147K
2,600 sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC Form 4

Evidence

4
SM
Slessor MikeDirector, CEO
FORMFORMFACTOR INC
Open-market sale · 10b5-1 plan
SELL$114K
900 sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC Form 4

Evidence

4
SM
Slessor MikeDirector, CEO
FORMFORMFACTOR INC
Open-market sale · 10b5-1 plan
SELL$229K
1,826 sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC Form 4

Evidence

4
SM
Slessor MikeDirector, CEO
FORMFORMFACTOR INC
Open-market sale · 10b5-1 plan
SELL$99K
767 sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC Form 4

Evidence

4
HM
Hoffmann MartinCEO
ONONOn Holding AG
Open-market sale · 10b5-1 plan
SELL$141K
4,150 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

1
SE
Susi Roger E.Director, CEO, President, Chairman, 10% Owner
IRMDIRADIMED CORP
Open-market sale · 10b5-1 plan
SELL$170K
1,847 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

1
SE
Susi Roger E.Director, CEO, President, Chairman, 10% Owner
IRMDIRADIMED CORP
Open-market sale · 10b5-1 plan
SELL$197K
2,107 sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC Form 4

Evidence

1
SE
Susi Roger E.Director, CEO, President, Chairman, 10% Owner
IRMDIRADIMED CORP
Open-market sale · 10b5-1 plan
SELL$238K
2,564 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

1
SE
Susi Roger E.Director, CEO, President, Chairman, 10% Owner
IRMDIRADIMED CORP
Open-market sale · 10b5-1 plan
SELL$55K
589 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

0
SD
Spector DavidDirector, Chairman & CEO
PFSIPennyMac Financial Services, Inc.
Open-market sale · 10b5-1 plan
SELL$39K
417 sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC Form 4

Evidence

0
SE
Susi Roger E.Director, CEO, President, Chairman, 10% Owner
IRMDIRADIMED CORP
Open-market sale · 10b5-1 plan
SELL$37K
393 sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC Form 4

Evidence

47
VR
Velaga S. RamPresident, ISG
AVGOBroadcom Inc.
Open-market sale
SELL$2.96M
8,000 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

42
CP
Coen Steven P.See remarks
DNAGinkgo Bioworks Holdings, Inc.
Open-market sale
SELL$213K
33.2K sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

41
LM
Lingenbrink MatthewDirector
FTLFFITLIFE BRANDS, INC.
Open-market purchase
BUY$29K
3,000 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

41
FM
Fitta Catherine MaryDirector
OCCIOFS Credit Company, Inc.
Open-market purchase
BUY$6,666
2,200 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

39
Wood Anthony J.Director, CEO and Chairman BOD, 10% Owner
ROKUROKU, INC
Open-market sale · 10b5-1 plan
SELL$1.40M
13.8K sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence